Adult stem cells for cardiac repair: A choice between skeletal myoblasts and bone marrow stem cells

Experimental Biology and Medicine

Volumn 231, Issue 1, 2006, Pages 8-19

  Ye, Lei ^a   Haider, Husnain Kh ^b   Sim, Eugene K W ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cell therapy; Heart failure; Myocytes; Stem cells; Transplantation

Indexed keywords

ANGIOGENESIS; CLINICAL TRIAL; HEART DISEASE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMATOPOIETIC STEM CELL; HUMAN; MUSCLE DEVELOPMENT; MYOBLAST; SHORT SURVEY; STEM CELL TRANSPLANTATION;

HARNESS;

EID: 30344453346     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020623100102     Document Type: Short Survey

References (115)

1. McGill CJ, Brooks G. Cell cycle control mechanisms and their role in cardiac growth. Cardiovasc Res 30:557-569, 1995.
2. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344:1750-1757, 2001.
3. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A 95:8801-8805, 1998.
4. Anversa P, Leri A, Kajstura J, Nadal-Ginard B. Myocyte growth and cardiac repair. J Mol Cell Cardiol 34:91-105, 2002.
5. Eriksson H. Heart failure: a growing public health problem. J Intern Med 237:135-141, 1995.
6. Koh GY, Soonpaa MH, Klug MG, Field LJ. Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium. Am J Physiol 264:H1727-1733, 1993.
7. Chou SM, Nonaka I. Satellite cells and muscle regeneration in diseased human skeletal muscles. J Neurol Sci 34:131-145, 1977.
8. Koh GY, Kim SJ, Klug MG, Park K, Soonpaa MH, Field LJ. Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J Clin Invest 95:114-121, 1995.
9. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102:898-901, 2000.
10. Suzuki K, Smolenski RT, Jayakumar J, Murtuza B, Brand NJ, Yacoub MH. Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation 102:III216-III221, 2000.
11. Gulbins H, Schrepfer S, Uhlig A, Goldemund A, Oberhoffer M, Reichenspurner H, Meiser B, Reichart B. Myoblasts survive intracardiac transfer and divide further after transplantation. Heart Surg Forum 5:340-344, 2002.
12. Chazaud B, Hittinger L, Sonnet C, Champagne S, Le Corvoisier P, Benhaiem-Sigaux N, Unterseeh T, Su J, Merlet P, Rahmouni A, Garot J, Gherardi R, Teiger E. Endoventricular porcine autologous myoblast transplantation can be successfully achieved with minor mechanical cell damage. Cardiovasc Res 58:444-450, 2003.
13. Borenstein N, Bruneval P, Hekmati M, Bovin C, Behr L, Pinset C, Laborde F, Montarras D. Noncultured, autologous, skeletal muscle cells can successfully engraft into ovine myocardium. Circulation 107:3088-3092, 2003.
14. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 98:2512-2523, 1996.
15. Reinecke H, Murry CE. Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing? Cardiovasc Pathol 96:337-344, 2000.
16. Sugimoto T, Inui K, Shimazaki Y. Gene therapy for myocardial angiogenesis: with direct intramuscular gene transfer of naked deoxyribonucleic acid encoding vascular endothelial growth factor and cell transplantation of vascular endothelial growth factor transfected H9c2 myoblast. Jpn J Thorac Cardiovasc Surg 51:192-197, 2003.
17. Ohno N, Fedak PW, Weisel RD, Mickle DA, Fujii T, Li RK. Transplantation of cryopreserved muscle cells in dilated cardiomyopathy: effects on left ventricular geometry and function. J Thorac Cardiovasc Surg 126:1537-1548, 2003.
18. Atkins BZ, Hueman MT, Meuchel J, Hutcheson KA, Glower DD, Taylor DA. Cellular cardiomyoplasty improves diastolic properties of injured heart. J Surg Res 85:234-242, 1999.
19. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4:929-933, 1998.
20. Thompson RB, Emani SM, Davis BH, van den Bos EJ, Morimoto Y, Craig D, Glower D, Taylor DA. Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells. Circulation 108:II264, 2003.
21. Marelli D, Ma F, Chiu RC. Satellite cell implantation for neomyocardial regeneration. Transplant Proc 24:2995, 1992.
22. Pouzet B, Vilquin JT, Hagege AA, Scorsin M, Messas E, Fiszman M, Schwartz K, Menasche P. Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized? Circulation 102:III210-215, 2000.
23. Suzuki K, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y, Yacoub MH. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104:I207-212, 2001.
24. Pouzet B, Ghostine S, Vilquin JT, Garcin I, Scorsin M, Hagege AA, Duboc D, Schwartz K, Menasche P. Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors? Circulation 104:I223-228, 2001.
25. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A 100:7808-7811, 2003.
26. Al Attar N, Carrion C, Ghostine S, Garcin I, Vilquin JT, Hagege AA, Menasche P. Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat. Cardiovasc Res 58:142-148, 2003.
27. Zhong H, Zhu H, Wei H, Zhang Z. Influence of skeletal muscle satellite cells implanted into infarcted myocardium on remnant myocyte volumes. Chin Med J 116:1088-1091, 2003.
28. Dib N, Diethrich EB, Campbell A, Goodwin N, Robinson B, Gilbert J, Hobohm DW, Taylor DA. Endoventricular transplantation of allogenic skeletal myoblasts in a porcine model of myocardial infarction. J Endovasc Ther 9:313-319, 2002.
29. Haider HKh, Ye Lei, Jiang SJ, Ge RW, Law PK, Chua T, Sim EKW. Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor. J Mol Med 82:539-549, 2004.
30. Ghostine S, Carrion C, Souza LC, Richard P, Bruneval P, Vilquin JT, Pouzet B, Schwartz K, Menasche P, Hagege AA. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 106:I131-136, 2002.
31. Suzuki K, Murtuza B, Suzuki N, Smolenski RT, Yacoub MH. Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicin-induced heart failure. Circulation 104:I213-217, 2001.
32. Rajnoch C, Chachques JC, Berrebi A, Bruneval P, Benoit MO, Carpentier A. Cellular therapy reverse myocardial dysfunction. J Thorac Cardiovasc Surg 121:871-878, 2001.
33. Yoon PD, Kao RL, Magovern GJ. Myocardial regeneration. Transplanting satellite cells into damaged myocardium. Tex Heart Inst J 22:119-125, 1995.
34. Haider HKh, Jiang SJ, Ye L, Aziz S, Law PK, Sim EK. Effectiveness of transient immunosuppression using cyclosporine for xenomyoblast transplantation for cardiac repair. Transplant Proc 36:232-235, 2004.
35. Pouzet B, Ghostine S, Elattar N, Hagege AA, Duboc D, Desnos M, Schwartz K, Vilquin JT, Menasche P. Long term functional results of autologous skeletal myoblast transplantation in rats. Circulation 104:599, 2001.
36. Balogh S, Naus CC, Merrifield PA. Expression of gap junctions in cultured rat L6 cells during myogenesis. Dev Biol 155:351-360, 1993.
37. Asakura A, Rudnicki MA. Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. Exp Hematol 30:1339-1345, 2002.
38. Hagege AA, Carrion C, Menasche P, Vilquin JT, Duboc D, Marolleau JP, Desnos M, Bruneval P. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361:491-492, 2003.
39. Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, Jacoby DB, Dinsmore JH, Wright S, Aretz TH, Eisen HJ, Aaronson KD. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41:879-888, 2003.
40. Rando TA, Pavlath GK, Blau HM. The fate of myoblasts following transplantation into mature muscle. Exp Cell Res 220:383-389, 1995.
41. Gussoni E, Blau HM, Kunkel LM. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 3:970-977, 1997.
42. Skuk D, Caron N, Goulet M, Roy B, Espinosa F, Tremblay JP. Dynamics of the early immune cellular reactions after myogenic cell transplantation. Cell Transplant 11:671-681, 2002.
43. Fan Y, Maley M, Beilharz M, Grounds M. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 19:853-860, 1996.
44. Guerette B, Asselin I, Skuk D, Entman M, Tremblay JP. Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation. Cell Transplant 6:101-107, 1997.
45. Merly F, Huard C, Asselin I, Robbins PD, Tremblay JP. Anti-inflammatory effect of transforming growth factor-beta1 in myoblast transplantation. Transplantation 65:793-799, 1998.
46. Pavlath GK, Rando TA, Blau HM. Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers. J Cell Biol 127:1923-1932, 1994.
47. Qu Z, Huard J. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy. Gene Ther 7:428-437, 2000.
48. Haider HKh, Lei Y, Shujia J, Sim EKW. Cellular myocardial reconstruction using human myoblasts. JACC 42:588-589, 2003.
49. Qu Z, Balkir L, van Deutekom JC, Robbins PD, Pruchnic R, Huard J. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 142:1257-1267, 1998.
50. Hodgetts SI, Grounds MD. Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5. Immunol Cell Biol 79:231-239, 2001.
51. Camirand G, Caron NJ, Turgeon NA, Rossini AA, Tremblay JP. Treatment with anti-CD154 antibody and donor-specific transfusion prevents acute rejection of myoblast transplantation. Transplantation 73:453-461, 2002.
52. Mitchell PJ, Johnson SE, Hannon K. Insulin-like growth factor I stimulates myoblast expansion and myofiber development in the limb. Dev Dyn 223:12-23, 2002.
53. Germani A, Di Carlo A, Mangoni A, Straino S, Giacinti C, Turrini P, Biglioli P, Capogrossi MC. Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol 163:1417-1428, 2003.
54. Kinoshita I, Vilquin JT, Tremblay JP. Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice. Muscle Nerve 18:834-841, 1995.
55. Menasche P, Hagege AA, Scorsin M, Pouzet B, Desnos M, Duboc D, Schwartz K, Vilquin JT, Marolleau JP. Myoblast transplantation for heart failure. Lancet 357:279-280, 2001.
56. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, Bel A, Sarateanu S, Scorsin M, Schwartz K, Bruneval P, Benbunan M, Marolleau JP, Duboc D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41:1078-1083, 2003.
57. Haider HKh, Tan AC, Aziz S, Chachques JC, Sim EK. Myoblast transplantation for cardiac repair: a clinical perspective. Mol Ther 9:14-23, 2004.
58. Dib N, McCarthy P, Campbell A, Dinsmore J, Yeager M, Pagani FD, Maclellan WR, Fonarow G, Eisen HJ, Furukawa S, Michler RE, Buchele D, Ghazoul M, Diethrich EB. Two year follow up of the safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: results from the United States experience. Circulation 108:IV623, 2003.
59. Herreros J, Prosper F, Perez A, Gavira JJ, Garcia-Velloso MJ, Barba J, Sanchez PL, Canizo C, Rabago G, Marti-Climent JM, Hernandez M, Lopez-Holgado N, Gonzalez-Santos JM, Martin-Luengo C, Alegria E. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 24:2012-2020, 2003.
60. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, Maat AP, Serruys PW. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 42:2063-2069, 2003.
61. Chachques JC, Herrreros J, Prosper F, Trainini J, Carpentier S, Carpentier AF. Autologous human serum for cell culture avoids the implantation of Cardioverter-defibrillators in cellular cardiomyoplasty. Circulation 108:IV 623, 2003.
62. Siminiak T, Fizser D, Jerzykowska O, Rozwadoska N, Rzezniczak J, Kurpisz M. Transplantation of autologous skeletal myoblasts in the treatment of patients with post infarction heart failure. Circulation 106:II636, 2002.
63. Law PK, Fang G, Chua F, Kakuchaya T, Bockeria, LA. First-in-man myoblast allografts for heart degeneration (abstract). Int J Med Implants Devices 1:100-155, 2003.
64. Zhang F, Gao X, Yiang ZJ, Ma W, Li C, Kao RL. Cellular cardiomyoplasty: a preliminary clinical report. Cardiovasc Radiat Med 4:39-42, 2003.
65. Ince H, Petzsch M, Rehders TC, Chatterjee T, Nienaber CA. Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction. J Endovasc Ther 11:695-704, 2004.
66. Makino SJ, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J. Cardiomyocytes can be generated from marrow stromal cells in vivo. J Clin Invest 103:697-705, 1999.
67. Bittira B, Kuang JQ, Al-Khaldi A, Shum-Tim D, Chiu RC. In vitro pre-programming of marrow stromal cells for myocardial regeneration. Ann Thorac Surg 74:1154-1159, 2002.
68. Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, Sakai T, Jia ZQ. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100:II247-256, 1999.
69. Min JY, Sullivan MF, Yang Y, Zhang JP, Converso KL, Morgan JP, Xiao YF. Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs. Ann Thorac Surg 74:1568-1575, 2002.
70. Agbulut O, Menot ML, Li Z, Marotte F, Paulin D, Hagege AA, Chomienne C, Samuel JL, Menasche P. Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicininduced cardiomyopathy. Cardiovasc Res 58:451-459, 2003.
71. Nishida M, Li TS, Hirata K, Yano M, Matsuzaki M, Hamano K. Improvement of cardiac function by bone marrow cell implantation in a rat hypoperfusion heart model. Ann Thorac Surg 75:768-773, 2003.
72. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, Masaki H, Mori Y, Iba O, Tateishi E, Kosaki A, Shintani S, Murohara T, Imaizumi T, Iwasaka T. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104:1046-1052, 2001.
73. Duan H-F, Wu CT, Wu DL, Lu Y, Liu HJ, Ha XQ, Zhang QW, Wang H, Jia XX, Wang LS. Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells over-expressing hepatocyte growth factor. Mol Ther 8:467-474, 2003.
74. Kudo M, Wang Y, Wani MA, Xu M, Ayub A, Ashraf M. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J Mol Cell Cardiol 35:1113-1119, 2003.
75. Matsuura K, Nagai T, Nishigaki N, Oyama T, Nishi J, Wada H, Sano M, Toko H, Akazawa H, Sato T, Nakaya H, Kasanuki H, Komuro I. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 279:11384-11391, 2004.
76. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228, 1999.
77. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, Imaizumi T. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103:2776-2779, 2001.
78. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 938:221-229, 2001.
79. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705, 2001.
80. Kuramochi Y, Fukazawa R, Migita M, Hayakawa J, Hayashida M, Uchikoba Y, Fukumi D, Shimada T, Ogawa S. Cardiomyocyte regeneration from circulating bone marrow cells in mice. Pediatr Res 54:319-325, 2003.
81. Fukuhara S, Tomita S, Nakatani T, Kishida A, Morisaki T, Yutani C, Kitamura S. Comparison of cell labeling procedures for bone marrow cell transplantation to treat heart failure: long-term quantitative analysis. Transplant Proc 34:2718-2721, 2002.
82. Kobayashi T, Hamano K, Li TS, Katoh T, Kobayashi S, Matsuzaki M, Esato K. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res 89:189-195, 2000.
83. Li TS, Hamano K, Hirata K, Kobayashi T, Nishida M. The safety and feasibility of the local implantation of autologous bone marrow cells for ischemic heart disease. J Card Surg 18:S69-75, 2003.
84. Hamano K, Li TS, Kobayashi T, Hirata K, Yano M, Kohno M, Matsuzaki M. Therapeutic angiogenesis induced by local autologous bone marrow cell implantation. Ann Thorac Surg 73:1210-1215, 2002.
85. Fuchs S, Baffour R, Zhou YF, Shou M, Pierre A, Tio FO, Weissman NJ, Leon MB, Epstein SE, Kornowski R. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37:1726-1732, 2001.
86. Vicario J, Piva J, Pierini A, Ortega HH, Canal A, Gerardo L, Pfeiffer H, Campos C, Fendrich I, Novero R, Monti A. Transcoronary sinus delivery of autologous bone marrow and angiogenesis in pig models with myocardial injury. Cardiovasc Radiat Med 3:91-94, 2002.
87. Tomita S, Mickle DA, Weisel RD, Jia ZQ, Tumiati LC, Allidina Y, Liu P, Li RK. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 123:1132-1140, 2002.
88. Yau TM, Tomita S, Weisel RD, Jia ZQ, Tumiati LC, Mickle DA, Li RK. Beneficial effect of autologous cell transplantation on infarcted heart function: comparison between bone marrow stromal cells and heart cells. Ann Thorac Surg 75:169-176, 2003.
89. Dick AJ, Guttman MA, Raman VK, Peters DC, Pessanha BS, Hill JM, Smith S, Scott G, McVeigh ER, Lederman RJ. Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in Swine. Circulation 108:2899-2904, 2003.
90. Kim EJ, Li RK, Weisel RD, Mickle DA, Jia ZQ, Tomita S, Sakai T, Yau TM. Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg 122:963-971, 2001.
91. Edelberg JM, Tang L, Hattori K, Lyden D, Rafii S. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res 90:E89-93, 2002.
92. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430-436, 2001.
93. Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: entity or function? Cell 105:829-841, 2001.
94. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, Sharkis SJ. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105:369-377, 2001.
95. Al-Khaldi AA, Elipoulos N, Lachapelle K, Galipeau J. VEGF dependent angiogenic response induced by ex-vivo cultured marrow stromal cells. Circulation 104(Suppl 2):II-123, 2001.
96. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, Field LJ. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664-668, 2004.
97. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428:668-673, 2004.
98. Hamano K, Nishida M, Hirata K, Mikamo A, Li TS, Harada M, Miura T, Matsuzaki M, Esato K. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J 65:845-847, 2001.
99. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106:3009-3017, 2002.
100. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kogler G, Wernet P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913-1918, 2002.
101. Stamm C, Westphal B, Kleine HD, Petzsch M, Kitter C, Klinge C, Schumichen C, Nienaber CA, Freund M, Steinhoff G. Autologous bone marrow stem-cell transplantaion for myocardial regentation. Lancet 361:45-46, 2003.
102. Tse HF, Kwong YL, Chan KF, Lo G, Ho CL, Lau CP. Angiogenesis in ischemic myocardium by intramyocardial autologous bone marrow mononuclear cellimplantation. Lancet 361:47-49, 2003.
103. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, Mesquita CT, Rossi MI, Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Belem L, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vaughn WK, Assad JA, Mesquita ET, Willerson JT. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107:2294-2302, 2003.
104. Fuchs S, Satler LF, Kornowski R, Okubagzi P, Weisz G, Baffour R, Waksman R, Weissman NJ, Cerqueira M, Leon MB, Epstein SE. Catheter-based autologous bone marrow myocardial injection in nooption patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol 41:1721-1724, 2003.
105. Beran G, Glogar D, Lang IM. Improved myocardial viability following intramyocardial autologous bone marrow injection after acute myocardial infarction. Heart 89:930, 2003.
106. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364:141-148, 2004.
107. Bel A, Messas E, Agbulut O, Richard P, Samuel JL, Bruneval P, Hagege AA, Menasche P. Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution. Circulation 108:II247-252, 2003.
108. Ott HC, Bonaros N, Marksteiner R, Wolf D, Margreiter E, Schachner T, Laufer G, Hering S. Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats. Eur J Cardiothorac Surg 25:627-634, 2004.
109. Suzuki K, Brand NJ, Allen S, Khan MA, Farrell AO, Murtuza B, Oakley RE, Yacoub MH. Overexpression of connexin 43 in skeletal myoblasts: relevance to cell transplantation to the heart. J Thorac Cardiovasc Surg 122:759-766, 2001.
110. Wang JS, Shum-Tim D, Galipeau J, Chedrawy E, Eliopoulos N, Chiu RC. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 120:999-1005, 2000.
111. Panek R, Jung US, Lin ZW, Lu GN, Gordon D, Karathanasis S. Age related impairment microvascular outgrowth is associated with loss of VEGF, Angiopoietin 1 and 2 expression. Circulation 104:II69, 2001.
112. Hayashi S, Asagami T, Wu B, Nakahashi T, Topper JN, Tsao P. Reduced angiogenesis in the setting of insulin resistance. Circulation 106:II239, 2002.
113. Yoon YS, Park JS, Tkebuchava T, Luedeman C, Losordo DW. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 109:3154-3157, 2004.
114. Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intra-coronary arterial injection of mesenchymal stromal cells and micro infarction in dogs. Lancet 363:783-784, 2004.
115. Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK Kim YJ, Soo Lee D, Sohn DW, Han KS, Oh BH, Lee MM, Park YB. Effects of intracoronary infusion of peripheral blood stem-cells mobilized with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomized clinical trial. Lancet 363:751-756, 2004.